I never cease to wonder at bitter old holders who cant see what...

I never cease to wonder at bitter old holders who cant see what the rest of the market sees plainly.
That SUD is a new company now, recapped, reborn, with a focus on CAR-T cell immune therapy and gene therapy.
Not only does it now own a suite of CAR-T therapy, but appointment by appointment Hopper is building a board if international first class experts in the various areas needed to build and run this new business.
I think he is building a successful CAR_T cell focused immunotherapy business here step by step over the long term. Just like he built the immunotherapy business of IMU.